Severe Retinopathy of Prematurity in Big Babies

Abstract

Background Evaluation of babies with gestational age (GA) over 32 weeks and with a birth weight (BW) over 1500 g, who underwent treatment for retinopathy of prematurity (ROP).

Materials and Methods The data of babies with ROP between June 2015 – 2020 were analyzed retrospectively and cross-sectionally. All infants treated for ROP were evaluated. Big babies who were older than 32 weeks GA with a BW higher than 1500 g were determined. Other treated premature infants formed the control group.

Results We retrospectively scanned 6581 patients who underwent ROP examination. Of these babies, 109 were treated for ROP. Thirteen babies (12%) who were treated for ROP were born over 32 weeks of GA and above the weight of 1500 g. One big infant was excluded because of missing file data. Eleven of these infants had type 1 ROP and 1 had aggressive posterior ROP. The mean GA and BW of big babies was 33.58 ± 0.88 weeks and 1860.83 ± 257.73 g, respectively. The mean GA and BW of the control group was 27.85 ± 2.02 weeks and 1068.28 ± 313.78 g, respectively. Both the big babies and the control group received oxygen treatment for 15.25 ± 11.44 and 19.17 ± 12.11 days (p = 0.29), respectively. Sepsis was seen in one big infant but 18 infants were observed to have sepsis in the control group. Similarly, one big infant had necrotizing enterocolitis (NEC), while in the control group, 12 infants had NEC.

Conclusions Total oxygen intake days, NEC, and sepsis rates were found to be relatively lower in big babies with severe ROP. This could suggest that other factors may have a greater effect on the development of severe ROP in big babies.

Zusammenfassung

Hintergrund Untersuchung von Säuglingen mit einem Gestationsalter von mehr als 32 Wochen und einem Geburtsgewicht von mehr als 1500 g, die wegen Frühgeborenenretinopathie (ROP) behandelt wurden.

Materialien und Methoden Die Daten von Säuglingen mit ROP zwischen Juni 2015 und 2020 wurden retrospektiv und im Querschnitt ausgewertet. Alle wegen ROP behandelten Säuglinge wurden untersucht. Große Säuglinge, die älter als 32 Wochen waren und ein Gewicht von mehr als 1500 g aufwiesen, wurden bestimmt. Andere behandelte Frühgeborene wurden als Kontrollgruppe eingesetzt.

Ergebnisse Wir haben retrospektiv 6581 Patienten untersucht, die sich einer ROP-Untersuchung unterzogen haben. 109 dieser Säuglinge wurden wegen ROP behandelt. 13 der Säuglinge (12%), die wegen ROP behandelt wurden, wurden mit einem Gestationsalter von mehr als 32 Wochen geboren und wogen mehr als 1500 g. Ein großer Säugling wurde wegen fehlender Daten ausgeschlossen. 11 dieser Säuglinge hatten eine Typ-1-ROP und 1 Säugling eine aggressive posteriore ROP. Das mittlere Gestationsalter und Geburtsgewicht der großen Säuglinge betrugen 33,58 ± 0,88 Wochen und 1860,83 ± 257,73 g. Das mittlere Gestationsalter und Geburtsgewicht der Kontrollgruppe betrugen 27,85 ± 2,02 Wochen und 1068,28 ± 313,78 g. Sowohl die großen Säuglinge als auch die Kontrollgruppe wurden 15,25 ± 11,44 und 19,17 ± 12,11 Tage lang mit Sauerstoff behandelt (p = 0,29). Bei 1 großen Säugling wurde eine Sepsis festgestellt, während in der Kontrollgruppe bei 18 Säuglingen eine Sepsis beobachtet wurde. Ähnlich war es bei 1 großen Säugling mit nekrotisierender Enterokolitis (NEC), während in der Kontrollgruppe 12 Säuglinge NEC hatten.

Schlussfolgerungen Die Gesamtzahl der Sauerstoffzufuhrtage, die NEC- und Sepsisraten waren bei großen Säuglingen mit schwerer ROP relativ niedrig. Dies kann ein Hinweis darauf sein, dass andere Faktoren einen größeren Einfluss auf die Entwicklung einer schweren ROP bei großen Säuglingen haben.

Key words

retinopathy of prematurity - big babies - risk factors - ablation treatment - anti-vascular endothelial growth factor - pediatric ophthalmology - retina

Schlüsselwörter

Frühgeborenenretinopathie - große Säuglinge - Risikofaktoren - Ablationsbehandlung - antivaskulärer endothelialer Wachstumsfaktor - Kinderophthalmologie - Retina

Publication History

Received: 19 September 2021

Accepted: 17 January 2022

Article published online:
14 April 2022

• References

• 1 Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet 2013; 382: 1445-1457
• 2 Sun Y, Hellström A, Smith LEH. Retinopathy of prematurity. In: Martin RJ, Fanaroff AA, Walsh MC. eds. Fanaroff and Martinʼs Neonatal Perinatal Medicine – Diseases of the Fetus and Newborn, 10th ed. Philadelphia, PA: Saunders Elsevier; 2015: 1767-1774
• 3 Fierson WM. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013; 131: 189-195
• 4 Pjaver RK, Bilagi AP, Vinekar A. et al. Evidence based ROP guidelines in the NNF Evidence based guidelines. 2010: 253-263 Accessed April 8, 2020 at: http://%20aimaonline.org/iap-neochap-2013/uploads/acd-corner/nnf_guidelines-2011.pdf
• 5 Shukla R, Murthy GVS, Gilbert C. et al. Operational guidelines for ROP in India: A summary. Indian J Ophthalmol 2020; 68: 108-114
• 6 Chen Y, Feng J, Gilbert C. et al. Time at treatment of severe retinopathy of prematurity in China: recommendations for guidelines in more mature infants. PLoS One 2015; 10: e0116669
• 7 Koç E, Baş AY, Özdek Ş. et al. Turkish Neonatal and Turkish Ophthalmology Societies consensus guideline on the retinopathy of prematurity. Turk Pediatri Ars 2018; 53: 151-160
• 8 Lynch AM, Wagner BD, Hodges JK. et al. The relationship of the subtypes of preterm birth with retinopathy of prematurity. Am J Obstet Gynecol 2017; 217: 354.e1-354.e8
• 9 Blencowe H, Lawn JE, Vazquez T. et al. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 2013; 74: 35-49
• 10 Carrion JZ, Fortes Filho JB, Tartarella MB. et al. Prevalence of retinopathy of prematurity in Latin America. Clin Ophthalmol 2011; 5: 1687-1695
• 11 Smith LEH. Pathogenesis of retinopathy of prematurity. Semin Neonatol 2003; 8: 469-473
• 12 Goncalves E, Nasser LS, Martelli DR. et al. Incidence and risk factors for retinopathy of prematurity in a Brazilian reference service. Sao Paulo Med J 2014; 132: 85-91
• 13 Bas AY, Demirel N, Koc E. et al. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. Br J Ophthalmol 2018; 102: 1711-1716
• 14 Gunay M, Celik G, Tuten A. et al. Characteristics of Severe Retinopathy of Prematurity in Infants with Birth Weight above 1500 Grams at a Referral Center in Turkey. PLoS One 2016; 11: e0161692
• 15 Çömez A, Çelemler P, Özmen MC. et al. Retinopathy of prematurity incidence and treatment modalities in moderate and late preterm infants: a study from two tertiary centers. Can J Ophthalmol 2021;
• 16 Arsan A, Toygar AK, Oguz SS. Turkish Neonatology Association Bronchopulmonary Dysplasia Prevention and Follow-up Guide. Turkey: Turkish Neonatology Association; 2018: 14
• 17 Celebi AR, Petricli IS, Hekimoglu E. et al. The incidence and risk factors of severe retinopathy of prematurity in extremely low birth weight infants in Turkey. Med Sci Monit 2014; 20: 1647-1653
• 18 Binenbaum G. Algorithms for the prediction of retinopathy of prematurity based on postnatal weight gain. Clin Perinatol 2013; 40: 261-270
• 19 Eckert GU, Fortes Filho JB, Maia M. et al. A predictive score for retinopathy of prematurity in very low birth weight preterm infants. Eye (Lond) 2012; 26: 400-406
• 20 Özbek E, Genel F, Atlıhan F. et al. Retinopathy Of Prematurity In Our Nenatal Intensive Care Unit, Incidence, Risk Factors And Outcome. Journal of Dr Behcet Uz Childrenʼs Hospital 2011; 1: 7-12
• 21 Eriş E, Perente İ, Seymen Z. et al. Assessment of frequency and major risk factors of retinopathy in prematures between years 2015 and 2016. Med J Bakirkoy 2018; 14: 204-208
• 22 Alajbegovic-Halimic J, Zvizdic D, Alimanovic-Halilovic E. et al. Risk Factors for Retinopathy of Prematurity in Premature Born Children. Med Arch 2015; 69: 409-413
• 23 Nugud AA, Nugud S, Nugud A. et al. Perinatal risk factors for development of retinopathy of prematurity in a tertiary neonatal intensive care unit. J Taibah Univ Med Sci 2019; 14: 306-311
• 24 Choi JY, Han YI, Kim JH. et al. The most important factors for retinopathy of prematurity in preterm infants. Korean J Perinatol 2014; 25: 153-158
• 25 Dikci S, Turgut H. Evaluation of the Relationship of Risk Factors Affecting the Development of Prematurity Retinopathy with the Severity*of the Disease. MN Ophthalmology 2019; 26: 27-31
• 26 Shah PK, Narendran V, Kalpana N. Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child Fetal Neonatal Ed 2012; 97: 371-375
• 27 Stenson BJ, Tarnow-Mordi WO, Darlow BA. et al. BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group. Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013; 368: 2094-2104
• 28 Askie LM, Brocklehurst P, Darlow BA. et al. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr 2011; 11: 6
• 29 Saugstad OD, Aune D. Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies. Neonatology 2014; 105: 55-63
• 30 Dwivedi A, Dwivedi D, Lakhtakia S. et al. Prevalence, risk factors and pattern of severe retinopathy of prematurity in eastern Madhya Pradesh. Indian J Ophthalmol 2019; 67: 819-823
• 31 Ekinci DY, Ugurlu A, Tasli NG. What is the incidence of retinopathy of prematurity (ROP) in ‘big’ babies?: results of a retrospective multicenter study. Ophthalmic Epidemiol 2020; 28: 138-143
• 32 Tiryaki Demir S, Karapapak M, Uslu HS. et al. Retinopathy screening results of late-preterm infants born at 32–35 weeks of gestational age. Graefes Arch Clin Exp Ophthalmol 2019; 257: 1325-1329